WallStreetZenWallStreetZen

NASDAQ: ANEB
Anebulo Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Anebulo Pharmaceuticals earnings were -$7.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ANEB earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$1.7M, down 31.9% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, ANEB reported annual earnings of -$8.2M, with -30.1% growth.

ANEB earnings history

Current Revenue
$0.0
Current Earnings
-$7.7M
Current Profit Margin
0%

ANEB Return on Equity

Current Company
-90.1%
Current Industry
-60.2%
Current Market
31.5%
ANEB's Return on Equity (-90.1%)... subscribe to Premium to read more.
High Return on Equity Performance

ANEB undefined

Current Company
-84.5%
Current Industry
-2.5%
ANEB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ANEB announces earnings.

ANEB undefined

Current Company
-53.97%
Current Industry
5.8%
ANEB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ANEB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ANEB-$7.27M-$7.69MN/A-$0.26
VRCA-$55.56M-$65.99MN/A-$1.14
CNTX-$27.55M-$27.63MN/A-$0.31
IRD-$58.60M-$58.62MN/A-$2.10
PMVP-$78.60M-$60.88MN/A-$1.18
View Top Biotech Stocks

Anebulo Pharmaceuticals Earnings Reports & History FAQ

What were Anebulo Pharmaceuticals's earnings last quarter?

On ANEB's earnings call on Invalid Date, Anebulo Pharmaceuticals (NASDAQ: ANEB) reported Q1 2025 earnings per share (EPS) of -$0.04, up 33.33% year over year. Total ANEB earnings for the quarter were -$1.68 million. In the same quarter last year, Anebulo Pharmaceuticals's earnings per share (EPS) was -$0.06.

If you're new to stock investing, here's how to buy Anebulo Pharmaceuticals stock.

Is Anebulo Pharmaceuticals profitable or losing money?

As of the last Anebulo Pharmaceuticals earnings report, Anebulo Pharmaceuticals is currently losing money. Anebulo Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$7.69 million, a 17.73% decrease year over year.

What was ANEB's earnings growth in the past year?

As of Anebulo Pharmaceuticals's earnings date in Invalid Date, Anebulo Pharmaceuticals's earnings has grown year over year. ANEB earnings in the past year totalled -$7.69 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.